Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
暂无分享,去创建一个
R. Hynes | S. Teitelbaum | F. Ross | K. Mchugh | M. Zheng | N. Namba | X. Feng | K. Hodivala-Dilke | J. Lam | D. Novack | X. Feng | Jonathan D. Lam | Xunqiang Feng | N. Namba
[1] S. Kitazawa,et al. Cloning and Characterization of the Murine b3 Integrin Gene Promoter: Identi®cation of an Interleukin-4 Responsive Element and Regulation by STAT-6 , 2001 .
[2] 井上 勝. Granulocyte macrophage-colony stimulating factor reciprocally regulate α[v]-associated integrins on murine osteoclast precursors , 1999 .
[3] R. Hynes,et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. , 1999, The Journal of clinical investigation.
[4] D. Towler,et al. Cloning of the murine beta5 integrin subunit promoter. Identification of a novel sequence mediating granulocyte-macrophage colony-stimulating factor-dependent repression of beta5 integrin gene transcription. , 1999, The Journal of biological chemistry.
[5] S. Goodman,et al. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist , 1999 .
[6] G. Rodan,et al. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells. , 1998, Endocrinology.
[7] R. Hynes,et al. Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins , 1998, Cell.
[8] A. Livolsi,et al. Tumor Necrosis Factor-α Activation of Nuclear Transcription Factor-κB in Marrow Macrophages Is Mediated by c-Src Tyrosine Phosphorylation of IκBα* , 1998, The Journal of Biological Chemistry.
[9] G. Rodan,et al. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. , 1998, The Journal of clinical investigation.
[10] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[11] S. Teitelbaum,et al. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. , 1997, The Journal of clinical investigation.
[12] M A Horton,et al. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. , 1997, The Journal of clinical investigation.
[13] P. Schlesinger,et al. Substrate Recognition by Osteoclast Precursors Induces C-src/Microtubule Association , 1997, The Journal of cell biology.
[14] S. Mckercher,et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 , 1997, Nature.
[15] M. Ginsberg,et al. Trans-dominant inhibition of integrin function. , 1996, Molecular biology of the cell.
[16] S. Kitazawa,et al. Interleukin-4 Induces Expression of the Integrin αvβ3 via Transactivation of the β3 Gene (*) , 1995, The Journal of Biological Chemistry.
[17] J. Delmez,et al. Modulation of renal osteodystrophy by extrarenal production of calcitriol. , 1995, American journal of nephrology.
[18] M. Schwartz,et al. Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.
[19] A. Fischer,et al. Mineral metabolism in infants with malignant osteopetrosis: Heterogeneity in plasma 1,25‐dihydroxyvitamin D levels and bone histology , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] M. Horton,et al. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. , 1991, Experimental cell research.
[21] Allan Bradley,et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.
[22] S. Teitelbaum,et al. Osteoclastic bone resorption by a polarized vacuolar proton pump. , 1989, Science.
[23] S. Teitelbaum,et al. 1,25-Dihydroxyvitamin D3 modulates bone marrow macrophage precursor proliferation and differentiation. Up-regulation of the mannose receptor. , 1987, The Journal of biological chemistry.
[24] S. Teitelbaum,et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. , 1980, The New England journal of medicine.